Interestingly, we observed a dose-dependent increase in phosphorylated AMPK (pAMPK) and a dose-dependent decrease in phosphorylated HER2 (pHER2) in HER2+ GC cells (Figure 1C). Here, ERBB2 is linked to gastric cancer.